tirzepatide and contrave How Compares to Other Weight Loss Medications — Shreveport Direct Care Weight Loss Drug Contrave Helped

Increased Risk Of Hypertrophic Scarring Patients who use GLP-1 medications prior to abdominoplasty have a nearly two-fold increased risk of hypertrophic scarring, according to a significant new study published in the Aesthetic Surgery Journal

Keep a food diary: Tracking what you eat and how your body responds can help identify triggers

& Iversen, P

After the FDA declared a semaglutide shortage in 2022, pharmacies, telehealth companies and other health care providers have been able to manufacture copycat versions of Novo Nordisks GLP-1 therapies

The first GLP-1 drug, exenatide (the brand name is Byetta), was approved in 2005